Welcome to the e-CCO Library!

P369: The comparative frequency of clostridial infection in patients with ulcerative colitis receiving mesenchymal stromal cells and anti-cytokine therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. Knyazev1, A. Kagramanova*1, M. Chernova2, I. Korneeva1, D. Kulakov1, A. Parfenov1

Created: Friday, 22 February 2019, 9:41 AM
P370 Endoscopic balloon dilatation in paediatric stricturing Crohn’s disease: A retrospective collaborative study of the paediatric IBD Porto group of ESPGHAN
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. Ledder1, J. Viala2, D. Urlep3, D. Serban4, L. De Ridder5, M. Martinelli6, C. Romano7, S. Oliva8, S. Sharma9, M. Thomson9, D. Turner1, Paediatric IBD Porto Group of ESPGHAN

Created: Thursday, 30 January 2020, 10:12 AM
P370: A randomised controlled trial of acceptance and commitment therapy for the treatment of stress in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mulcahy H.*1, Wynne B.2, McHugh L.2, Rowan C.1, Byrne K.1, Keegan D.1, Hartery K.1, Dooley B.2

Created: Wednesday, 20 February 2019, 10:36 AM
P370: Concomitant azathioprine prevents new-onset arthralgia after initiation of vedolizumab: A retrospective cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Kokkotis, G.(1);Zampeli, E.(2);Tzouvala, M.(3);Giotis, I.(3);Orfanos, P.(4);Benetou, V.(4);Stoupaki, M.(2);Gizis, M.(1);Kioulos, N.(1);Kitsou, V.(1);Leontidis, N.(3);Leonidakis, G.(2);Chatzinikolaou, M.L.(1);Perlepe, N.(1);Koutsounas, I.(1);Lagiou, P.(4);Michopoulos, S.(2);Bamias, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P370: Correlation of the IBD Disk with intestinal ultrasound in patients with inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: KatsarosMD- PhD- Gastroenterologist, M.(1)*;Kalogirou, M.(1);Katsoula, A.(1);Paschos, P.(2);Karabatsou, S.(1);Tsionis, T.(1);Soufleris, K.(3);Giouleme, O.(1);
Created: Friday, 14 July 2023, 11:05 AM
P370: Endosponge-assisted early surgical closure of ileal pouch-anal anastomotic leakage improves long-term outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.A. Wasmann1*, M.A. Reijntjes1, M.E. Stellingwerf1, C.I. Ponsioen2, C.J. Buskens1, P.J. Tanis1, W.A. Bemelman1

Created: Thursday, 21 February 2019, 9:14 AM
P370: Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase 3 study U ACHIEVE maintenance
Year: 2022
Source: ECCO'22
Authors: Panés, J.(1);Loftus, E.V.J.(2);Higgins, P.(3);Lindsay, J.O.(4);Zhou, W.(5);Yao, X.(5);Ilo, D.(5);Phillips, C.(5);Tran, J.(5);Sanchez Gonzalez, Y.(5);Vermeire, S.(6);
Created: Friday, 11 February 2022, 3:52 PM
P370: Quality of life of patients with inflammatory bowel diseases in remission on different forms of treatment
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Kalaba*1, M. Markovic2, M. Jankovic1, D. Zaric1, S. Markovic1, P. Svorcan1

Created: Friday, 22 February 2019, 9:41 AM
P370: Treatment patterns in a managed care project with inflammatory bowel disease patients in Germany: CEDnetz study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Bokemeyer*1, J. Langbrandtner2, P. Jessen3, J. Büning4, S. Schreiber5, H. Raspe2, A. Hüppe2

Created: Friday, 22 February 2019, 9:49 AM
P371 Self-medication with analgesics in ulcerative colitis: Results of a patient survey
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Rodríguez-Lago1, F. Mesonero Gismeno2, M. Cañas3, C. Savini4, R. Saldaña4, L. Feo-Lucas5, S. Fernandez5, L. Cea-Calvo5, B. Juliá5

Created: Thursday, 30 January 2020, 10:12 AM
P371: Assessment Of Postoperative Complications Following Ileocecal Resection In Crohn's Disease From A Low-To-Middle Income Country
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Benammi, S.(1)*;Naddouri, J.(1);Bakkali, Y.(1);Alaoui, M.(1);Sebbah, F.(1);Raiss, M.(1);Hrora, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P371: Concentrations of 6-thioguanine nucleotide correlate with both infliximab and adalimumab levels in patients with inflammatory bowel disease on combination therapy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Kelly*, A. Trajkovski, A. Weizman, G. Nguyen, A. H. Steinhart, M. Silverberg, K. Croitoru

Created: Friday, 22 February 2019, 9:49 AM
P371: Healthcare maintenance in inflammatory bowel disease patients: need for a top down approach
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hazel K., Forry M., Patchett S., O'Toole A.

Created: Wednesday, 20 February 2019, 10:36 AM
P371: Outcome of immediate infliximab optimisation based on rapid assessment of serum drug and faecal calprotectin concentrations in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Farkas*1, K. Szántó1, D. Kata2, A. Bálint1, Á. Milassin1, A. Fábián1, R. Bor1, M. Rutka1, Z. Szepes1, I. Soós1, F. Nagy1, I. Földesi2, T. Molnár1

Created: Friday, 22 February 2019, 9:41 AM
P371: The addition of intravenous, high dose, bolus of methyl-prednisolone increases the early clinical response to oral corticosteroids in moderately active ulcerative colitis. Preliminary results of a prospective, controlled, multicentre, randomised, open-label study.
Year: 2022
Source: ECCO'22
Authors: Domènech MoralPhD, E.(1);Llaó, J.(2);Mañosa, M.(1);Martín-Arranz, E.(3);Zabana, Y.(4);Navarro-Llavat, M.(5);Garcia-Planella, E.(6);Busquets, D.(7);Pineda, J.R.(8);Monfort, D.(9);Gutiérrez, A.(10);García-Alonso, F.J.(11);Menchén, L.A.(12);Villoria, A.(13);
Created: Friday, 11 February 2022, 3:52 PM
P371: Using digital monitoring during the COVID pandemic to streamline outpatient appointments
Year: 2021
Source: ECCO'21 Virtual
Authors: Walsh, A.J.(1);Matini, L.(1);Wilson, J.(1);Lyden, S.(1);Al-Hillawi, L.(1);Kantschuster, R.(1);Kormilitzin, A.(2);Smith, T.(1);Slater, J.(1);Payton, S.(1);White, L.(1);Woodley, H.(1);Brain, O.(1);Palmer, R.(1);Ambrose, T.(1);Satsangi, J.(1);Travis, S.P.L.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P371: Vedolizumab is associated with changes in innate rather than T-cell immunity in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Zeissig1,2*, E. Rosati3, C.M. Dowds3,4, K. Aden2,3, J. Bethge2, B. Schulte2, W.H. Pan3, M. Falk-Paulsen3, C. Conrad2, D. Schuldt2, A. Sinha3, S. Nikolaus2, A. Arlt2, D. Kabelitz4, M. Ellrichmann2, P. Rosenstiel3, A. Franke3, S. Schreiber2,3

Created: Thursday, 21 February 2019, 9:14 AM
P372 Effects of filgotinib on anaemia, thrombocytopenia and leukopenia: Phase 3 study results in patients with active rheumatoid arthritis and prior inadequate response/intolerance to biological DMARDs
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Besuyen1, M. Genovese2, K. de Vlam3, J.E. Gottenberg4, K. Kalunian5, B. Bartok6, Y. Tan7, Y. Guo8, C. Tasset1, J. Sundy9, D. Walker10, T. Takeuchi11

Created: Thursday, 30 January 2020, 10:12 AM
P372: A pilot study: A psychological support service for patients with inflammatory bowel disease (PSSPIBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. McGeer1*, A. Ascott1, J. Eccles2, M. Smith1, L. Page2, E. Hills1, A. St-clair Jones1, J. Gregory2

Created: Thursday, 21 February 2019, 9:14 AM